Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats.
Study Goal
The researchers aimed to determine whether psilocybin could alleviate behavioral despair and cognitive deficits induced by chronic stress in a rodent model, focusing on its interaction with the HPA axis and ECS.
Results Summary
Psilocybin significantly reduced stress-induced behavioral despair and cognitive impairments, likely through ECS-mediated downregulation of the HPA axis, suggesting sustained therapeutic benefits for stress-related disorders.
Population
Male Wistar rats exposed to chronic stress via predator odor and social instability.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
psilocybin | decrease | stress-induced behavioral despair | male Wistar rats | - | significantly reduced | #1 |
psilocybin | decrease | cognitive impairments | male Wistar rats | - | significantly reduced | #2 |
psilocybin | decrease | stress-related behavioral disturbances | male Wistar rats | - | has sustained beneficial effects | #3 |
psilocybin | decrease | stress-related cognitive disturbances | male Wistar rats | - | has sustained beneficial effects | #4 |
Chronic stress exerts profound effects on mental health, contributing to disorders such as depression, anxiety, and cognitive impairment. This study examines the potential of psilocybin to alleviate behavioral despair and cognitive deficits in a rodent model of chronic stress, focusing on the interplay between the Hypothalamic-Pituitary-Adrenal (HPA) axis and the Endocannabinoid System (ECS). Twenty-two male Wistar rats were divided into control and stress groups. Animals within the stress group were exposed to predator odor and chronic social instability to induce chronic stress, and were either sham treated, or given psilocybin. Behavioral assessments were conducted using the Open Field Test, Sucrose Preference Test, Novel Object Recognition, Elevated Plus Maze, and Forced Swimming Test to evaluate locomotion, anhedonia, memory, anxiety, and behavioral despair, respectively. Blood and brain samples were analyzed for biochemical markers. Results indicated that psilocybin significantly reduced stress-induced behavioral despair and cognitive impairments, likely through ECS-mediated downregulation of the HPA axis. These findings suggest that early intervention with psilocybin has sustained beneficial effects on stress-related behavioral and cognitive disturbances, underscoring its potential as a novel therapeutic approach for stress-related mental health disorders.